GlobeNewswire by notified

Justeringer til prospekter, Investeringsforeningen Maj Invest

Share

Hermed offentliggøres opdaterede prospekter for samtlige afdelinger i Investeringsforeningen Maj Invest.

Opdateringen omfatter: 

  • Indsættelse af henvisning til de nye RTS-bilag under afdelingernes investeringsstrategier
  • Layoutmæssige forbedringer af de nye RTS-bilag

Prospekterne er vedhæftet denne meddelelse og kan ligeledes tilgås via foreningens hjemmeside.

For eventuelle spørgsmål kontakt Lise Bøgelund Jensen, direktør i foreningens investeringsforvaltningsselskab, på telefon 33 28 28 28.


Med venlig hilsen 

Investeringsforeningen Maj Invest


Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

LIfT BioSciences announces breakthrough preclinical data demonstrating the dual mode of action commonly believed necessary for curing solid tumours21.3.2023 08:00:00 CET | Press release

LIfTBioSciences announces breakthroughpreclinical data demonstrating thedualmode of actioncommonly believed necessary for curing solid tumours IMANp is the world’s first neutrophil-based cell therapy,generated from the haematopoietic stem cells ofdonors with exceptional anti-cancer innate immunityCombined cytotoxic and immunomodulatory mechanismsmark a major advancement in thedevelopment of novel solid tumour cancer treatmentsDestruction of cancer cells, recruitment of host immune system and favourableremodelling of the immunosuppressive tumour microenvironment across all solid tumour types testedClinical trials to commence in H1 2024 London,21 March 2023–LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy, today announces exciting preclinical data demonstrating that its Immunomodulatory Alpha Neutrophil product (IMANp) possesses both cytotoxic and immunomodulatory functionalities that are co

Ahold Delhaize share buyback update21.3.2023 08:00:00 CET | Press release

Zaandam, the Netherlands, March 21, 2023 – Ahold Delhaize has repurchased 500,000 of its common shares in the period from March 13, 2023 up to and including March 17, 2023. The shares were repurchased at an average price of € 30.09 per share for a total consideration of € 15 million. These repurchases were made as part of the € 1 billion share buyback program announced on November 9, 2022. The total number of shares repurchased under this program to date is 6,417,795 common shares for a total consideration of € 182.2 million. Download the share buyback transactions excel sheet for detailed individual transaction information from https://www.aholddelhaize.com/en/investors/share-buyback-programs/2023/ This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs.

Pegasus Acquisition Company Europe B.V. - 2022 Annual Report publication, convening of AGM and initiation of liquidation process21.3.2023 07:56:48 CET | Press release

AMSTERDAM , March 21, 2023 (GLOBE NEWSWIRE) -- Pegasus Acquisition Company Europe B.V. (“Pegasus Europe” or the “Company”) today published its annual report for the year 2022. The full report can be downloaded from the Investor Relations section of the Pegasus Europe website via the following link. (https://www.pegasuseurope.com/images/uploads/documents/Annual_report_2022.pdf) Pegasus Europe has also convened its Annual General Meeting (“AGM”) to be held on May 2, 2023 at 15:00 hours CEST. The convening notice and corresponding documents can also be found on the Pegasus Europe website via the following link. (https://www.pegasuseurope.com/investor-relations/pace) The Company will not conclude a Business Combination ahead of the deadline of May 3, 2023 as defined in the Company's IPO prospectus (the "Prospectus") as approved by the Dutch Authority for the Financial Markets (the "AFM") on April 29, 2021. The co-CEOs of the Company have recommended to the Board of Directors, which has una

CGG, TGS and BGP Complete Phase IV of 3D Multi-Client Survey Offshore Suriname21.3.2023 07:30:00 CET | Press release

Paris, France – March21, 2023 CGG, a global technology and HPC leader, in a consortium with TGS and BGP, today announced the completion of Phase IV of the deepwater 3D seismic survey offshore Suriname. Fast-track products for this recently completed Phase IV will be ready for review towards the middle of this year, with the final products for the entire program available in late 2023. Covering 1,800 sq km, Phase IV completes the programmed 14,500 sq km survey of newly acquired 3D data in deep and shallow water in the promising Guyana-Suriname basin. The program also includes over 6,400 sq km of reprocessed data. These new multi-client data will support Suriname’s deep and shallow water bid rounds. Dechun Lin, EVP, Earth Data, CGG, said: “We are pleased to have completed Phase IV of this major survey withour consortium partners, TGS and BGP.With our in-depth knowledge of the Suriname-Guyana region and leadership inhigh-endimaging technologies, CGG will deliver the high-resolution, high-

SkiStar Half-Year Report September 2022-February 202321.3.2023 07:15:00 CET | Press release

CONTINUED GROWTH AND A VERY STRONG PROFIT FOR THE IMPORTANT SECOND QUARTER Second Quarter Net sales for the second quarter increased by SEK 172 million (8 percent) to SEK 2,350 (2,178) million compared with the same period of the previous year.Profit before tax for the second quarter improved by SEK 6 million (1 percent) to SEK 926 (920) million compared with the same period of the previous year.Earnings per share before and after dilution amounted to SEK 9.32 (9.57). First Six Months Net sales for the first six months of the year increased by SEK 195 million (8 percent) to SEK 2,527 (2,333) million compared with the same period of the previous year.Profit before tax for the first six months of the year decreased by SEK 122 million (21 percent) to SEK 451 (573) million compared with the same period of the previous year.Earnings per share before and after dilution amounted to SEK 4.35 (5.61), a decline of 22 percent. Significant events during and after the period The profit before tax f